Chat with us, powered by LiveChat

Past

Purpose, passion and innovation: 3 key drivers for Tech4Good progress

In a world where the desire to create a positive impact on society and the environment is growing, the significance of purpose-driven work is becoming increasingly evident. Recent research by McKinsey & Co revealed that 70 percent of employees now derive their sense of purpose from work, presenting a promising opportunity for Tech4Good organisations. At …

Purpose, passion and innovation: 3 key drivers for Tech4Good progress Read More »

European Teratology Society (ETS)

We were delighted announce that Lhasa Principal Scientist, Alun Myden presented our award winning paper ‘Using adverse outcome pathways to contextualise (Q)SAR predictions for reproductive toxicity – A case study with aromatase inhibition’, at the 51st Annual meeting of the ETS conference. The award winning-paper, co-authored by Senior Scientist, Emma White and Head of Toxicology, …

European Teratology Society (ETS) Read More »

25th North American ISSX Meeting

We were excited to attend the International Society for the Study of Xenobiotics meeting, in Boston, Massachusetts! The meeting, one of the world’s largest gatherings of researchers in xenobiotics, offered innovative short courses, symposia, lectures and other events. It provided an exceptional opportunity for researchers, from academia and industry alike, to gather, network, and exchange …

25th North American ISSX Meeting Read More »

EUROTOX Congress 2023

We were excited to attend EUROTOX 2023, which took place from 10 to 13 September in Slovenia! Monday 11th September, 09:30 AM. Scientist, Tasha Jones presented “Development of a network of adverse outcome pathways (AOPs) associating immunosuppression with cancer”. The poster itself outlines a preliminary network of AOPs linking MIEs leading to immunosuppression and resulting …

EUROTOX Congress 2023 Read More »

Streamlining your drug development workflow using purge calculations

Thank you to those who attended our webinar, ‘Streamlining your drug development workflow using purge calculations’. We were delighted to have Senior Principal Scientist Andy Teasdale presenting . Andy is the chair of AstraZeneca’s Impurity advisory Board, and has developed a wealth of knowledge over the last 30 years working in the pharmaceutical industry. He …

Streamlining your drug development workflow using purge calculations Read More »

12th World Congress on Alternatives and Animal Use in the Life Sciences

Did you attend WC12 at Niagara Falls, Canada? The annual World Congress on Alternatives and Animal Use in the Life Sciences congress brings together multidisciplinary stakeholders from academia, industry, government, and non-profit sectors under one roof to advance the 3Rs—to reduce, refine, and replace the use of animals in the life sciences. Application Scientist, Charlie …

12th World Congress on Alternatives and Animal Use in the Life Sciences Read More »

UKEMS 2023

We were excited to attend UKEMS annual meeting which was held at the Clontarf Castle Hotel, Dublin from 2nd – 5th July! UKEMS, as the UK branch of the European Environmental Muta-Genesis Society (EEMGS), exists to serve those scientists working in the UK in the area of DNA damage and mutations caused by environmental agents …

UKEMS 2023 Read More »

Harnessing cutting-edge carcinogenicity data to support your toxicity assessments

We recently held our webinar ‘Harnessing cutting-edge carcinogenicity data to support your toxicity assessments’. In this free to-attend virtual event, Lhasa Senior Scientist, Andrew Thresher presented the latest innovations in the Lhasa Carcinogenicity Database (LCDB). The LCDB is a freely available database of in vivo carcinogenicity study information, which includes TD50 values as a measure …

Harnessing cutting-edge carcinogenicity data to support your toxicity assessments Read More »

The Institute of Process Research and Development meeting

We were delighted to be attend the University of Leeds for the Institute of Process Research and Development (IPRD) meeting. The occasion marked the 15th anniversary of the IPRD, which brings together internationally-leading expertise in chemistry and engineering to support manufacturing process innovation.   Lhasa Senior Scientist, Samuel Boobier presented at this exciting event.   Discover …

The Institute of Process Research and Development meeting Read More »

Using next generation carcinogenicity assessments to make confident human safety decisions

In this Lhasa webinar we discussed alternative approaches to carcinogenicity assessment with Dr. Todd Bourcier (FDA) and Dr. Gina Hilton (PETA). Within many sectors of the life sciences industry, animal testing is still considered a primary option for toxicity testing, and as a result is used heavily. The limitations of this model are now well …

Using next generation carcinogenicity assessments to make confident human safety decisions Read More »